Group One Trading’s Ovid Therapeutics OVID Stock Holding History

Group One Trading’s Portfolio OVID Stock Details OVID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.1K	Buy	5,000 +500	+11%	+$894	﹤0.01%	6321
2025 Q4	$7.33K	Sell	4,500 -130,000	-97%	-$200K	﹤0.01%	6987
2025 Q3	$175K	Buy	+134,500	New	+$117K	﹤0.01%	4810
2021 Q4	–	Sell	-233,500	Closed	-$785K	–	8682
2021 Q3	$785K	Sell	233,500 -161,400	-41%	-$589K	﹤0.01%	3679
2021 Q2	$1.54M	Sell	394,900 -43,900	-10%	-$173K	﹤0.01%	2913
2021 Q1	$1.76M	Buy	438,800 +417,200	+1,931%	+$1.39M	﹤0.01%	2606
2020 Q4	$50K	Buy	21,600 +20,000	+1,250%	+$93.2K	﹤0.01%	5006
2020 Q3	$9K	Buy	+1,600	New	+$10.7K	﹤0.01%	5464

Other funds holding OVID

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

SVCM

Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Group One Trading's OVID Position: Q1 2026 in Review

Group One Trading opened a new position in Ovid Therapeutics (OVID) in Q1 2026: 13,246 shares worth $29.4K. The stake represents ﹤0.01% of the portfolio and ranks #5685 among its holdings. This is a return to the name: Group One Trading previously reported a position in OVID as recently as Q3 2025.

Group One Trading first reported a position in OVID in Q2 2020 and has held it in 12 quarters since. The position peaked at $669K in Q1 2021. 103 funds tracked by Wall St. Rank hold OVID as of Q1 2026.

Group One Trading held 13,246 shares of Ovid Therapeutics worth $29.4K as of Q1 2026.
Ovid Therapeutics was a new Group One Trading position in Q1 2026.
Ovid Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5685 holding.
Group One Trading first reported a position in Ovid Therapeutics in Q2 2020 and has held it in 12 quarters since.
Group One Trading's Ovid Therapeutics position peaked at $669K in Q1 2021.
103 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.